costs were valued by using unit prices. The outcome for the economic evaluation was mean survival time as determined by the … an increase in the average total cost per patient of 6795 euros (EUR; 1998 values), when costs were assessed over the …, which is associated with an increase in costs for the Belgian health insurance system. …

. Results: From the viewpoint of the society, average total per-patient direct and indirect costs accruing over 3 months were … values], despite higher initial hospitalisation costs of the combination therapy. Abciximab plus urokinase was the dominant … plus urokinase in the PROMPT trial translated into cost savings in terms of reduced direct medical costs at 3 months. These …

antibacterials, thus further increasing costs due to prolonged hospitalisation, treatment of relapses and the use of more expensive … emergence of resistance, thus prolonging their clinical utility, but also reduce the costs associated with treating the … infection through rapid symptom improvement and earlier patient discharge. Numerous methods for reducing costs in patients with …

Objective: To use the population attributable risk (PAR) to estimate the treatment costs resulting from nonsteroidal … obtained from Dutch national hospital discharge records and tariffs. Annual treatment costs of NSAID-induced GI events were ….5 million to EUR98 million]. More than 65% of these NSAID-induced costs, EUR38 million, can be attributed to long term users of …

conflict; older generic drugs have lower acquisition costs but often impose longer recovery times. Longer recovery periods can … increase costs by prolonging the time to discharge from labour-intensive areas such as the operating suite or the …

collected data. Design: We analysed individual costs in a sample of women with UI who were identified in the framework of a …-related costs. On the basis of this information, we estimated the direct costs associated with UI from the perspective of the …

Objective: To examine the medical costs and effectiveness of acute treatment with imipramine versus acute treatment … 18-month costs and outcomes associated with these treatment scenarios based on the medical literature and clinician … imipramine utilising uniform dosage procedures and validated response criteria. Costs were calculated based on standardised …

) patient-specific costs of palliative care of HCC; and (ii) individual factors that drive patient-specific costs and to develop …, including costs of formal and informal services incurred by payers, caregivers and patients. Observational data from a large … Hong Kong cancer care programme were used. A regression analysis was performed using formal costs only, with the cost per …